Hisamitsu Pharmaceutical Co., Inc. Reports Consolidated Earnings Results for the Six Months Ended August 31, 2021
October 14, 2021 at 02:00 am EDT
Share
Hisamitsu Pharmaceutical Co., Inc. reported consolidated earnings results for the six months ended August 31, 2021. For the period, the company reported net sales of JPY 58,551 million against JPY 52,926 million a year ago. Operating profit was JPY 5,706 million against JPY 5,516 million a year ago. Profit was JPY 5,145 million against JPY 3,813 million a year ago. Profit per share was JPY 61.20 against JPY 45.22 a year ago. Diluted profit per share was JPY 61.16 against JPY 45.16 a year ago.
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
HISAMITSU PHARMACEUTICAL CO., INC. 
